Bacterial conjunctivitis is one of the most common eye-related diseases in the USA.
It affects around 135 people in 10,000 annually.
Conjunctivitis Clinical Study
In our relentless pursuit of effective treatments, we conducted a pivotal clinical trial to evaluate a study drug in patients with mild to moderate COVID-19.
This clinical trial represented a critical milestone in the drug development process, as it marked the final stages before potential approval. Our primary objective was to assess the safety, efficacy, and tolerability of the study drug in patients diagnosed with mild to moderate cases of COVID-19.
Current Status
Not Recruiting
Total Studies
01
Enrollment Process
Clinical trials are essential for advancing medical knowledge and improving patient care by testing the efficacy and safety of potential treatments before they are widely available to the public. Here’s what you can expect when considering enrollment.
Recruitment
Recruiting volunteers is the first step of an active clinical trial.
Phone Screening
You will undergo a phone screening to determine your eligibility.
Informed Consent
You must sign an ICF defining the purpose, procedure, potential risks & benefits, and your rights as participants.
